EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis

Song Gong, Lizhi Han, Yang Wang, Yong Feng, Ruoyu Wang, Shizhan Zhang, Kun Nie, Bo Wang, Fei Du, Jianzhong Guan, Lu Zhang, Jiangtao Liu und 1 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0345372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Song Gong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, DNA Methylation, Promoter Regions, Genetic, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Natural Science Foundation of Hubei Province, the Funding for Scientific Research Projects from the Wuhan Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucocorticoid (GC)-induced osteonecrosis of the femoral head (ONFH) involves bone marrow-derived mesenchymal stem cell (BMSC) apoptosis and dysregulated osteo-adipogenic differentiation. While aberrant H19 promoter methylation and expression have been linked to various bone metabolic disorders such as osteoporosis and osteosarcoma, their specific role in the pathogenesis of GC-induced ONFH remains largely unexplored.

Methods

We analyzed H19 promoter methylation, DNMTs , and H19 expression in human ONFH BMSCs. Roles of Dnmt1 and H19 in osteogenic/adipogenic differentiation were assessed using staining (Alizarin Red/Oil Red O) and pathway analysis. Effects of Dnmt1 knockdown or H19 overexpression were tested via BMSC implantation in a GC-induced ONFH rat model.

Results

H19 promoter hypomethylation caused H19 overexpression in undifferentiated GC-ONFH BMSCs; expression decreased upon differentiation. H19 and Dnmt1 expression were negatively correlated. Dnmt1 predominated among DNMTs in epigenetically regulating H19 and reciprocally modulated differentiation (inhibiting osteogenesis, promoting adipogenesis). Conversely, H19 promoted osteogenesis and inhibited adipogenesis by suppressing GSK-3β , activating Wnt/β-catenin signaling. In the rat model, implanted BMSCs with Dnmt1 knockdown or H19 overexpression reduced empty lacunae, corrected the osteo-adipogenic imbalance, and delayed progression.

Conclusion

The Dnmt1 / H19 / GSK-3β axis reciprocally regulates BMSC osteogenic and adipogenic differentiation in GC-induced ONFH, representing a novel epigenetic mechanism underlying GC-induced ONFH and a promising MSC-based therapeutic strategy for early-stage disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsDNA MethylationPromoter Regions, GeneticGlucocorticoidsRNA, Long NoncodingOsteonecrosisFemur Head NecrosisAnimalsHumansDNA (Cytosine-5-)-Methyltransferase 1RatsOsteogenesisMaleCell DifferentiationAdipogenesisBone Marrow CellsRats, Sprague-DawleyGlycogen Synthase Kinase 3 betaWnt Signaling Pathway

Substanzen

H19 long non-coding RNADNA (Cytosine-5-)-Methyltransferase 1GlucocorticoidsRNA, Long NoncodingDnmt1 protein, ratGlycogen Synthase Kinase 3 betaDNMT1 protein, human

Autor:innen und Institutionen

  • Department of Orthopaedics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Orthopedics, The First Affiliated Hospital of Bengbu Medical University, Anhui Key Laboratory of Tissue Transformation, Bengbu Medical University, Bengbu, Anhui Province, P.R. China.
  • Department of Rehabilitation, Wuhan No.1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
  • Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Weihua Xu

Förderung

  • the National Natural Science Foundation of China
  • the Natural Science Foundation of Hubei Province
  • the Funding for Scientific Research Projects from the Wuhan Municipal Health Commission
  • the Scientific Research Project of the Anhui Provincial Education Department
  • The Excellent Research Innovation Team of the Anhui Provincial Education Department
  • the Wuhan Central Hospital Scientific Research Project

Zitieren

APA

Gong, S., Han, L., Wang, Y., Feng, Y., Wang, R., Zhang, S., Nie, K., Wang, B., Du, F., Guan, J., Zhang, L., Liu, J., & Xu, W. (2026). Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis. PLOS One. https://doi.org/10.1371/journal.pone.0345372

Vancouver

Gong S, Han L, Wang Y, Feng Y, Wang R, Zhang S, et al. Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis. PLOS One. 2026. doi:10.1371/journal.pone.0345372

BibTeX
@article{Gong2026,
  author = {Gong, Song and Han, Lizhi and Wang, Yang and Feng, Yong and Wang, Ruoyu and Zhang, Shizhan and Nie, Kun and Wang, Bo and Du, Fei and Guan, Jianzhong and Zhang, Lu and Liu, Jiangtao and Xu, Weihua},
  title = {Glucocorticoid-Induced alterations in DNA methylation in the H19 promoter of Bone Marrow-Derived Mesenchymal Stem Cells are associated with the pathogenesis of osteonecrosis},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0345372}
}
Kostenlos starten →